Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Rheum webbianum extract is an ethanolic preparation derived from the Himalayan medicinal plant *Rheum webbianum* Royle. It is being investigated for its chemopreventive and anticancer properties, particularly in the context of colorectal cancer. The extract demonstrates antiproliferative and antimigratory effects in colorectal adenocarcinoma cells (such as HT-29) and shows protective efficacy in animal models of 1,2-dimethylhydrazine (DMH)-induced colon carcinogenesis. Its mechanism of action involves the downregulation of β-catenin and TGF-β1 expression, thereby inhibiting oncogenic Wnt/β-catenin and pro-metastatic TGF-β signaling pathways. Additionally, it has been observed to restore rectal tissue architecture and reduce inflammatory lesions and dysplasia.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on rheum webbianum extract.